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HEPATIC HAEMANGOPMA: ENUCLEATE OR RESECT?
ABSTRACT
Kuo, P. C., Lewis, W. D. and Jenkins, R. L. (1994) Treatment ofgiant hemangiomas of
the liver by enucleation. Journal of the American College ofSurgeons; 178: 49-53.
Cavernous hemangiomas are the most common benign tumors of the liver. The results of
natural history studies have demonstrated that asymptomatic hemangiomas can be
observed without deleterious results. The appropriate treatment for symptomatic cavern-
ous hemangiomas remains unclear. Since 1987, ten patients with symptomatic giant
cavernoushemangiomashave undergone simple enucleation at theNew EnglandDeacon-
ess Hospital, Boston, Massachusetts. Ten patients who underwent both anatomic and
nonanatomic resections for benign hepatic tumors were chosen as a control group. We
analyzed patient demographics and characteristics of the hospital course. Both groups
had similar periods of hospitalization (9.5 _+ 1.2 versus 9.1 __+ 1.8 days; p NS), operative
time (2.2 +_ 0.3 versus 2.4 + 0.2 hours; p NS) and lesion size (7.6 _+ 1.3 versus 8.4 + 1.2
centimeters; p NS). The enucleation group had 49 percent less intraoperative blood loss
whencompared with the resection group (400+_ 129 versus 742 +_ 116 millimiters;
p < 0.05). Two units of blood were transfused in the enucleation group while 6 units were
transfused in the resection group. Postoperatively, two patients in the resection group
required computed tomographic guided drainage of extrahepatic bile collections. There
were none in the enucleation group. Because enucleation is performed in the fibrous
capsule composed of compressed hepatic parenchyma, injury to major bile ducts and
blood vessels may be avoided. Enucleation is a safe alternative to resection for treatment
of symptomatic giant hemangiomas. J. Am. Coll. Surg., 1994, 178:49-53.
KEY WORDS: Hepatic haemangioma
haemangioma
liver resection enucleation of hepatic276 HPB INTERNATIONAL
PAPER DISCUSSION
In this paper Kuo et al. suggest that enucleation of
hemangioma is better than formal liver resection with
less operative bleeding, less operative blood trans-
fusion, and less postoperative surgical complications.
The rationale of enucleation is based on the premise
that there is a fibrous pseudocapsule around the hema-
ngioma with few vessels and bile ducts crossing the
capsule allowing bloodless dissection1. The technique
used by Kuo et al. for enucleation includes full mobiliz-
ation of the liver, clamping of the hepatic pedicle and
blunt finger dissection of the hemangioma inside the
pseudocapsular plane. Results of the enucleation of
hemangioma in 10 patients were compared to those of
formal liver resection in 10 patients with benign liver
tumors, focal nodular hyperplasia or liver adenomas.
Most tumors were located in the right liver. The mean
diameter of hemangiomas was 7 cm and that of other
tumors was 8 cm. Estimated blood loss was 46% lower
in the enucleation group than in the resected group and
blood transfusion was less (2 units vs 6 units). There
were no intraabdominal complication after enuclea-
tion while there were 2 subphrenic abcesses after for-
mal liver resection.
These data reflect the results previously presented
both by other surgical groups 1’2 and by our own team
suggesting that enucleation of liver hemangiomas is
easy and safe. Is the evidence strong enough to propose
enucleation as the procedure of choice in the treatment
of liver hemangiomas ? This should probably be tem-
pered by a certain number of arguments. First of all
a comparison between enucleation of liver hema-
ngioma and formal liver resection for benign liver
tumors might not be fair. Liver parenchyma in the
vicinity of a large solid liver mass, particularly in
patients with oral contraceptive induced adenomas,
may be more susceptible to bleed during transection
than liver parenchyma of patients with hemangiomas.
Bleeding in patients with oral contraceptive induced
adenomas results from marked sinusoidal congestion
observed in more than 50% of these patients 3. In the
same way, it should be emphasized that formal liver
resection in patients with hemangioma are amongst
the easiest liver resection even when the tumor is large.
Division of the artery and portal branch supplying the
par,t of the liver to be resected markedly decreases the
volume and tenseness of the tumor. As a result liver
resection is usually performed as if there was not even
a tumor in the liver. Blood loss during liver resection of
benign liver tumors and particularly of hemangiomas
should be minimal whatever the size of the tumor and
the type of resection when a proper technique is used.
In our own experience, only 3% of patients with liver
resection for a benign tumor needed intra and/or pos-
toperative blood transfusion4. The difficulty of enuc-
leation of a tumor is quite variable depending upon its
location, near the liver edge or deeply inside the liver.
In the latter case, transection of liver parenchyma
surrounding the tumor is a prerequisite to enucleation
and the resection plane may be much larger
after enucleation than after any type of anatomical
liver resection. In addition, brisk bleeding may
occur when the hemangioma is close to a major liver
vessel. The technique of enucleation described by
Kuo et al. includes full mobilization of the liver.
As a matter of fact it has been shown that in large
tumors most of intraoperative bleeding occurs during
mobilization time Altogether, this suggests that there
is no definite supportive evidence that enuclea-
tion of liver hemangiomas is better than formal liver
resection. Small hemangiomas and hemangiomas which
are located superficiallymay be quite easily enucleated.
Large hemangiomas and those located deeply inside
the liver or in the immediate vicinity of a large liver
vessel (particularly a major hapatic vein) should prefer-
ably be resected by formal liver resection.
This report also rises several questions about the
indications for resection of benign liver tumors and
particularly of hemangiomas. Resection of hema-
ngiomas should be considered in only a very few
patients with symptomatic tumors. As in patients with
gallbladder stones, the analysis ofsymptoms should be
very cautious. In our experience, abdominal pain re-
lated to liver hemangioma is quite unfrequent. In most
patients with liver hemangiomas, abdominal pain is of
colonic origin. A very few patients with liver hema-
ngioma present with an inflammatory syndrome re-
sulting from central necrosis of the tumor6. Finally, the
risk ofrupture is quite low7. Ifresection is considered in
a patient with liver hemangioma, everything should be
done to avoid blood loss and blood transfusion includ-
ing surgical technique, planned autotransfusion and
intraoperative hemodilution 8.
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Editorial:Partial portacaval shunt:Narrow diameter H-graft by J.A. Myburgh.
Ref HPB Surgery; 8(1) 57-59
COMMENT BY R. ADAM AND H. BISMUTH
Professor Myburgh’s commentary makes several inter-
esting observations about our paper. However, we
would like to discuss his comment that by extrapola-
tion of our results it can be assumed that 68% of our
patients with calibrated porta caval shunts lost hepa-
topetal portal perfusion.
In patients with lOmm grafts, our data showed
that hepatopetal flow was maintained at 1 year in
7 of 10 patients (70%) who underwent arteriogra-
phy. Logically ifthese findings are extrapolated to
our series of 19 patients with lOmm grafts one
would expect to find-hepatopetal flow in 13 pa-
tients.
-In patients with 12mm grafts, as Professor
Myburgh states, the earlier work of Sarfeh and his
colleagues 1’2 using a combination of fluoroscopy
and selective angiography demonstrated that only
1 of their 12 patients receiving a 12-14mm graft
maintained pro-grade portal flow at one week
after surgery. Therefore, wemay assume that none
of the four patients with 12mm grafts of our series
have maintained prograde portal flow.
In patients with 8mm grafts, as nine of the 11
patients of Sarfeh’s series maintain prograde por-
tal flow, wemay assume that our two patients with
8mm graft would have retained prograde flow.
Overall consideration of our 25 patients gives a total
of 15 patients (60%) who retained prograde flow and
not 32% as suggested by Professor Myburgh. Never-
theless we would agree with him that there is no
absolute correlation between the occurrence of en-
cephalopathy and maintained por.tal venous perfusion.
In this respect, the work of Sarfeh (2) revealed a cor-
relation between the occurence ofencephalopathy and
the presence of reversed flow (35% encephalopathy in
those with reversed portal flow compared with 9% in
patients with prograde portal flow p 0.02) but other
workers have reported that factors other than straight-
forward preservation of pro-grade portal flow are
involved in the development of post operative an-
cephalopathy-for example, augmentation of hepatic
arterial perfusion of the liver after partial decom-
pression
3 and maintenance of mesenteric venous hy-
pertension limiting the absorption of nitrogenous
compounds’.
We are currently evaluating the long term results of
surgery in these patients and in further patients with
cirrhosis who have undergone the calibrated partial
portocaval shunt. The results in our series which now
stands at 43 patients tends to support the earlier work.
Namely, the operative mortality rate is low (2%), the
rate ofvariceal re-bleeding remains low (2%) and acute
encephalopathy was seen in 4 patients (9%) and chro-
nic encephalopathy in 2(5%). The actuarial survival at
five years is 82%. These results augment Professor